Want to join the conversation?
$FEYE 2Q15 PR: For 2015, the company currently expects total revenue in the range of $630 to $645MM. On a non-GAAP basis, total billings in the range of $840 to $850MM. Gross margin in the range of 71-74% of total revenue. Loss per share to be $1.70-1.80. Cash flow from operations in the range of negative $10MM to positive $10MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?